PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.40 -0.01 (-2.44%)
At close: Oct 2, 2026 · 4:00 PM EDT

PharmaCyte Biotech (PMCB) Income from Non-Controlling Interests (2023 - 2025)

Updated

PharmaCyte Biotech (PMCB) posted Income from Non-Controlling Interests of -$3.05 million for fiscal Q3 2025 (quarter ended Jan 31, 2025), compared with -$5.62 million a year earlier.

Analysis

PharmaCyte Biotech (PMCB) Income from Non-Controlling Interests (2023 - 2025) Analysis & Trends

For the trailing twelve months through Jan 31, 2025, Income from Non-Controlling Interests at PharmaCyte Biotech was -$13.88 million.

  • Quarterly Income from Non-Controlling Interests has run from a low of -$5.62 million in fiscal Q3 2024 to a high of -$2.26 million in fiscal Q2 2024 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -2.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -7.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 10.00 Mn
10 PharmaCyte Biotech 4.29 Mn 4.29 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2025 -3.05 Mn
Oct 31, 2024 -2.96 Mn
Jan 31, 2024 -5.62 Mn
Oct 31, 2023 -2.26 Mn
API Access

PharmaCyte Biotech Income from Non-Controlling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=PMCB&period=max&api_key=YOUR_API_KEY